NCT06557850 - A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

March 30, 2026

Study Completion Date

September 29, 2026

Conditions

Thyroid Eye Disease

Interventions

DRUG

Lu AG22515

Solution for infusion

Trial Locations (6)

RECRUITING

Diagnostic-Consultative Center Alexandrovska, Sofia

RECRUITING

"University Specialized Hospital for Active Treatment in Endocrinology (USHATE) Acad. Ivan Penchev", Sofia

RECRUITING

University Clinical Center of The Republic Of Srpska, Banja Luka

RECRUITING

Jagiellonian University Medical College, Krakow

RECRUITING

Uniewrsyteckie Centru Kliniczne, Katowice

RECRUITING

UnivCentrum Zdrowia MDM EB GROUP Sp.zo.o, Warsaw

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY